Obeticholic Acid
Tsanangudzo
Obeticholic acid (INT-747) ine simba, inosarudza uye inobata nemuromo FXR agonist ine EC50 ye99 nM.Obeticholic acid ine anticholeretic uye anti-kuzvimba mhedzisiro.Obeticholic acid zvakare inokonzeresa autophagy [1] [2] [3].
Background
Obeticholic Acid (6alpha-ethyl-chenodeoxycholic acid, 6-ECDCA, INT-747) ine simba uye inosarudza agonist yeFXR ine EC50 kukosha kwe99 nM [1].
Iyo farnesoid X receptor (FXR) inyukireya bile acid receptor inobatanidzwa mu bile acid homeostasis, chiropa fibrosis, hepatic uye intestinal kuzvimba uye chirwere chemoyo [2].
Obeticholic Acid ine simba uye inosarudza FXR agonist ine anticholeretic chiitiko [1].Obeticholic Acid is semisynthetic bile acid derivative uye ine simba FXR ligand.Mune estrogen-induced cholestasis rats, 6-ECDCA yakachengetedzwa kubva kune cholestasis inokonzerwa ne17α-ethynylestradiol (E217α) [2].Mu cirrhotic portal hypertension (PHT) rat modhi, INT-747 (30 mg/kg) yakadzoreredza nzira yechiratidzo yeFXR yakadzika uye yakaderedza kudzvinyirirwa kwepamhepo nekudzikisa zvachose intrahepatic vascular resistance (IHVR) pasina deleterious systemic hypotension.Ichi chiitiko chakabatanidzwa nekuwedzera kweNOS chiitiko [3].Mumuenzaniso weDahl rat wemunyu-sensitive hypertension uye insulin-resistance (IR), munyu wakanyanya (HS) kudya kwakawedzera zvakanyanya systemic blood pressure uye yakaderedzwa tishu DDAH kutaura.INT-747 yakawedzera insulin senitivity uye yakadzivisa kuderera kweDDAH kutaura [4].
References:
[1].Pellicciari R, Fiorucci S, Camaioni E, et al.6alpha-ethyl-chenodeoxycholic acid (6-ECCDA), ane simba uye anosarudza FXR agonist akapiwa anticholestatic basa.J Med Chem, 2002, 45(17): 3569-3572.
[2].Fiorucci S, Clerici C, Antonelli E, et al.Dziviriro mhedzisiro ye6-ethyl chenodeoxycholic acid, farnesoid X receptor ligand, mune estrogen-induced cholestasis.J Pharmacol Exp Ther, 2005, 313(2): 604-612.
[3].Verbeke L, Farre R, Trebicka J, et al.Obeticholic acid, farnesoid X receptor agonist, inovandudza portal hypertension nenzira mbiri dzakasiyana mumakonzo e cirrhotic.Hepatology, 2014, 59(6): 2286-2298.
[4].Ghebremariam YT, Yamada K, Lee JC, et al.FXR agonist INT-747 inogadzirisa kutaura kweDDAH uye inowedzera insulin senitivity mumakonzo ane munyu wakanyanya.PLoS One, 2013, 8(4): e60653.
Product Citation
- 1. Selina Costa."Kuita Novel Ligand yeFarnesoid X Receptor uchishandisa Transgenic Zebrafish."Yunivhesiti yeToronto.Jun-2018.
- 2. Kent, Rebeka."Migumisiro yeFenofibrate paCYP2D6 uye Regulation ye ANG1 uye RNASE4 neFXR Agonist Obeticholic Acid."indigo.uic.edu.2017.
Storage
Upfu | -20°C | 3 years |
4°C | 2 years | |
In solvent | -80°C | 6 mwedzi |
-20°C | 1 mwedzi |
Chimiro chemakemikari
Related Biological Data
Related Biological Data
Proposal18Quality Consistency Evaluation mapurojekiti akatenderwa4,uye6mapurojekiti ari pasi pekubvumidzwa.
Yepamberi yepasirese yemhando manejimendi system yakaisa hwaro hwakasimba hwekutengesa.
Kutariswa kwemhando yepamusoro kunofamba kuburikidza nehupenyu hwese kutenderera kwechigadzirwa kuti ive nechokwadi chemhando nekurapa.
Professional Regulatory Affairs timu inotsigira zvinodiwa zvemhando panguva yekushandisa uye kunyoreswa.